-
1
-
-
0041358796
-
Diabetic retinopathy and diabetic macular edema: Pathophysiology, screening, and novel therapies
-
Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 2003;26:2653-2664.
-
(2003)
Diabetes Care
, vol.26
, pp. 2653-2664
-
-
Ciulla, T.A.1
Amador, A.G.2
Zinman, B.3
-
2
-
-
0033400347
-
The pathogenesis of edema in diabetic maculopathy
-
Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 1999;14:223-232.
-
(1999)
Semin Ophthalmol
, vol.14
, pp. 223-232
-
-
Antcliff, R.J.1
Marshall, J.2
-
3
-
-
0022347471
-
Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1
-
Early Treatment Diabetic Retinopathy Study Research Group
-
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806.
-
(1985)
Arch Ophthalmol
, vol.103
, pp. 1796-1806
-
-
-
4
-
-
0033512868
-
When and how to do a grid laser for diabetic macular edema
-
Bandello F, Lanzetta P, Menchini U. When and how to do a grid laser for diabetic macular edema. Doc Ophthalmol 1999; 97:415-419.
-
(1999)
Doc Ophthalmol
, vol.97
, pp. 415-419
-
-
Bandello, F.1
Lanzetta, P.2
Menchini, U.3
-
5
-
-
7444245438
-
Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial
-
Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 2004;111:2044-2049.
-
(2004)
Ophthalmology
, vol.111
, pp. 2044-2049
-
-
Sutter, F.K.1
Simpson, J.M.2
Gillies, M.C.3
-
6
-
-
0842267262
-
Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: Preliminary results of a prospective controlled trial
-
Massin P, Audren F, Haouchine B, Bergmann JF, Benosman R, Caulin C, Gaudric A. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-225.
-
(2004)
Ophthalmology
, vol.111
, pp. 218-225
-
-
Massin, P.1
Audren, F.2
Haouchine, B.3
Bergmann, J.F.4
Benosman, R.5
Caulin, C.6
Gaudric, A.7
-
7
-
-
33747623255
-
Intravitreal triamcinolone for refractory diabetic macular edema: Two-year results of a double-masked, placebo-controlled, randomized clinical trial
-
Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006;113:1533-1538.
-
(2006)
Ophthalmology
, vol.113
, pp. 1533-1538
-
-
Gillies, M.C.1
Sutter, F.K.2
Simpson, J.M.3
Larsson, J.4
Ali, H.5
Zhu, M.6
-
8
-
-
33745884399
-
Intravitreal triamcinolone acetonide for diabetic macular edema: A prospective, randomized study
-
DOI 10.1089/jop.2006.22.200
-
Jonas JB, Kamppeter BA, Harder B, Vossmerbaeumer U, Sauder G, Spandau UH. Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study. J Ocul Pharmacol Ther 2006;22:200-207. (Pubitemid 44051133)
-
(2006)
Journal of Ocular Pharmacology and Therapeutics
, vol.22
, Issue.3
, pp. 200-207
-
-
Jonas, J.B.1
Kamppeter, B.A.2
Harder, B.3
Vossmerbaeumer, U.4
Sauder, G.5
Spandau, U.H.M.6
-
9
-
-
33748260374
-
Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial
-
DOI 10.1111/j.1600-0420.2006.00700.x
-
Audren F, Erginay A, Haouchine B, et al. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial, Acta Ophthalmol Scand 2006;84:624-630. (Pubitemid 44317541)
-
(2006)
Acta Ophthalmologica Scandinavica
, vol.84
, Issue.5
, pp. 624-630
-
-
Audren, F.1
Erginay, A.2
Haouchine, B.3
Benosman, R.4
Conrath, J.5
Bergmann, J.-F.6
Gaudric, A.7
Massin, P.8
-
10
-
-
25844513658
-
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
-
Cunningham ET Jr, Adamis AP, Altaweel M, et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005;112:1747-1757.
-
(2005)
Ophthalmology
, vol.112
, pp. 1747-1757
-
-
Cunningham Jr., E.T.1
Adamis, A.P.2
Altaweel, M.3
-
11
-
-
33748957021
-
A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema
-
Chun DW, Heier JS, Topping TM, Duker JS, Bankert JM. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 2006;113:1706-1712.
-
(2006)
Ophthalmology
, vol.113
, pp. 1706-1712
-
-
Chun, D.W.1
Heier, J.S.2
Topping, T.M.3
Duker, J.S.4
Bankert, J.M.5
-
12
-
-
33845745774
-
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
-
Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
-
(2006)
Retina
, vol.26
, pp. 999-1005
-
-
Haritoglou, C.1
Kook, D.2
Neubauer, A.3
-
13
-
-
33947542681
-
Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (Macugen) in diabetic retinopathy
-
Starita C, Patel M, Katz B, Adamis AP. Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (Macugen) in diabetic retinopathy. Dev Ophthalmol 2007;39: 122-148.
-
(2007)
Dev Ophthalmol
, vol.39
, pp. 122-148
-
-
Starita, C.1
Patel, M.2
Katz, B.3
Adamis, A.P.4
-
14
-
-
0036323373
-
Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin
-
Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC Jr. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 2002;80: 667-677.
-
(2002)
J Neurochem
, vol.80
, pp. 667-677
-
-
Antonetti, D.A.1
Wolpert, E.B.2
Demaio, L.3
Harhaj, N.S.4
Scaduto Jr., R.C.5
-
15
-
-
0036943831
-
Diabetic retinopathy: More than meets the eye
-
Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002;47:S253-S262.
-
(2002)
Surv Ophthalmol
, vol.47
-
-
Gardner, T.W.1
Antonetti, D.A.2
Barber, A.J.3
Lanoue, K.F.4
Levison, S.W.5
-
16
-
-
23944480405
-
Angiogenic pathways in diabetic retinopathy
-
Aiello LP. Angiogenic pathways in diabetic retinopathy. N Engl J Med 2005;353:839-841.
-
(2005)
N Engl J Med
, vol.353
, pp. 839-841
-
-
Aiello, L.P.1
-
17
-
-
11144239923
-
For the VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration
-
Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, for the VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351: 2805-2816.
-
(2004)
N Engl J Med
, vol.351
, pp. 2805-2816
-
-
Gragoudas, E.S.1
Adamis, A.2
Cunningham Jr., E.T.3
Feinsod, M.4
Guyer, D.R.5
-
18
-
-
2442621619
-
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
-
Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004;3:391-400.
-
(2004)
Nat Rev Drug Discov
, vol.3
, pp. 391-400
-
-
Ferrara, N.1
Hillan, K.J.2
Gerber, H.P.3
Novotny, W.4
-
19
-
-
33646464279
-
Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage
-
Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26:275-278.
-
(2006)
Retina
, vol.26
, pp. 275-278
-
-
Spaide, R.F.1
Fisher, Y.L.2
-
20
-
-
20144372969
-
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Twelve-week results of an uncontrolled open-label clinical study
-
Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 2005;112:1035-1047.
-
(2005)
Ophthalmology
, vol.112
, pp. 1035-1047
-
-
Michels, S.1
Rosenfeld, P.J.2
Puliafito, C.A.3
Marcus, E.N.4
Venkatraman, A.S.5
-
21
-
-
33644502828
-
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
-
Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113:363-372.
-
(2006)
Ophthalmology
, vol.113
, pp. 363-372
-
-
Avery, R.L.1
Pieramici, D.J.2
Rabena, M.D.3
Castellarin, A.A.4
Nasir, M.A.5
Giust, M.J.6
-
22
-
-
33646446084
-
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study
-
Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006;26:279-284.
-
(2006)
Retina
, vol.26
, pp. 279-284
-
-
Iturralde, D.1
Spaide, R.F.2
Meyerle, C.B.3
-
23
-
-
33947581702
-
Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: Results from the Pan-American collaborative retina study group at 6-month follow-up
-
Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, et al. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007;114: 743-750.
-
(2007)
Ophthalmology
, vol.114
, pp. 743-750
-
-
Arevalo, J.F.1
Fromow-Guerra, J.2
Quiroz-Mercado, H.3
-
24
-
-
34748876124
-
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema
-
Diabetic Retinopathy Clinical Research Network
-
Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007;114:1860-1867.
-
(2007)
Ophthalmology
, vol.114
, pp. 1860-1867
-
-
-
25
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444.
-
(2006)
N Engl J Med
, vol.355
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
-
26
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
-
(2006)
N Engl J Med
, vol.355
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
-
27
-
-
33847130442
-
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema
-
Diabetic Retinopathy Clinical Research Network
-
Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007;114:525-536.
-
(2007)
Ophthalmology
, vol.114
, pp. 525-536
-
-
-
28
-
-
33746679982
-
Diabetic macular edema: Correlation between microperimetry and optical coherence tomography findings
-
Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Invest Ophthalmol Vis Sci 2006;47:3044-3051.
-
(2006)
Invest Ophthalmol Vis Sci
, vol.47
, pp. 3044-3051
-
-
Vujosevic, S.1
Midena, E.2
Pilotto, E.3
Radin, P.P.4
Chiesa, L.5
Cavarzeran, F.6
-
29
-
-
36749003833
-
Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits
-
Gaudreault J, Fei D, Beyer JC, et al. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits. Retina 2007;27:1260-1266.
-
(2007)
Retina
, vol.27
, pp. 1260-1266
-
-
Gaudreault, J.1
Fei, D.2
Beyer, J.C.3
-
30
-
-
13944266313
-
Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration
-
Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V. Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 2005; 46:726-733.
-
(2005)
Invest Ophthalmol Vis Sci
, vol.46
, pp. 726-733
-
-
Gaudreault, J.1
Fei, D.2
Rusit, J.3
Suboc, P.4
Shiu, V.5
-
31
-
-
36549039554
-
Pharmacokinetics of intravitreal ranibizumab (Lucentis)
-
Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology 2007;114:2179-2182.
-
(2007)
Ophthalmology
, vol.114
, pp. 2179-2182
-
-
Bakri, S.J.1
Snyder, M.R.2
Reid, J.M.3
Pulido, J.S.4
Ezzat, M.K.5
Singh, R.J.6
-
32
-
-
0842288850
-
Temporal variation in diabetic macular edema measured by optical coherence tomography
-
DOI 10.1016/j.ophtha.2003.05.031
-
Frank RN, Schulz L, Abe K, et al. Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology 2004;111:211-217. (Pubitemid 38183216)
-
(2004)
Ophthalmology
, vol.111
, Issue.2
, pp. 211-217
-
-
Frank, R.N.1
Schulz, L.2
Abe, K.3
Iezzi, R.4
-
33
-
-
33644860109
-
Diurnal variation in clinically significant diabetic macular edema measured by the Stratus OCT
-
Polito A, Del Borrello M, Polini G, Furlan F, Isola M, Bandello F. Diurnal variation in clinically significant diabetic macular edema measured by the Stratus OCT. Retina 2006; 26:14-20.
-
(2006)
Retina
, vol.26
, pp. 14-20
-
-
Polito, A.1
Del Borrello, M.2
Polini, G.3
Furlan, F.4
Isola, M.5
Bandello, F.6
-
34
-
-
33845501347
-
Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema
-
Diabetic Retinopathy Clinical Research Network
-
Diabetic Retinopathy Clinical Research Network. Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. Arch Ophthalmol 2006;124:1701-1707.
-
(2006)
Arch Ophthalmol
, vol.124
, pp. 1701-1707
-
-
|